Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.29 HKD
−233.41 M HKD
84.65 M HKD
655.90 M
About HUA MEDICINE
Sector
CEO
Li Chen
Headquarters
Shanghai
Website
Founded
2009
FIGI
BBG00LVHG0W8
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2552 is 1.32 HKD — it has decreased by −15.38% in the past 24 hours. Watch HUA MEDICINE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUA MEDICINE stocks are traded under the ticker 2552.
2552 stock has fallen by −18.01% compared to the previous week, the month change is a −13.16% fall, over the last year HUA MEDICINE has showed a −31.25% decrease.
We've gathered analysts' opinions on HUA MEDICINE future price: according to them, 2552 price has a max estimate of 2.05 HKD and a min estimate of 2.05 HKD. Watch 2552 chart and read a more detailed HUA MEDICINE stock forecast: see what analysts think of HUA MEDICINE and suggest that you do with its stocks.
2552 reached its all-time high on Aug 17, 2020 with the price of 9.00 HKD, and its all-time low was 1.03 HKD and was reached on Sep 3, 2024. View more price dynamics on 2552 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2552 stock is 30.00% volatile and has beta coefficient of 0.41. Track HUA MEDICINE stock price on the chart and check out the list of the most volatile stocks — is HUA MEDICINE there?
Today HUA MEDICINE has the market capitalization of 1.30 B, it has decreased by −2.50% over the last week.
Yes, you can track HUA MEDICINE financials in yearly and quarterly reports right on TradingView.
HUA MEDICINE is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
2552 net income for the last half-year is −154.14 M HKD, while the previous report showed −130.87 M HKD of net income which accounts for −17.78% change. Track more HUA MEDICINE financial stats to get the full picture.
No, 2552 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 177.00 employees. See our rating of the largest employees — is HUA MEDICINE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUA MEDICINE EBITDA is −392.27 M HKD, and current EBITDA margin is −393.98%. See more stats in HUA MEDICINE financial statements.
Like other stocks, 2552 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUA MEDICINE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUA MEDICINE technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUA MEDICINE stock shows the sell signal. See more of HUA MEDICINE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.